Alnylam announces new management appointments

Cambridge, mass.--(business wire)--alnylam pharmaceuticals, inc. (nasdaq: alny), the leading rnai therapeutics company, today announced the appointment of two new members to the management team – piyush sharma as chief ethics & compliance officer (ceco), and evan lippman in the newly created role of chief corporate development and strategy officer (cdso). both executives will report to chief executive officer, yvonne greenstreet. “attracting and retaining top talent is one of my top priorit
ALNY Ratings Summary
ALNY Quant Ranking